Table 3

Convergent and divergent validity of the five-item version of the ETS for subjects with current pain (n=102): Pearson correlation, significance level (two tailed), patients (n)

Correlation
Significance level
Patients (n)
ETSLOT-R
Optimism
LOT-R
Pessimism
PHQ-9RS-11BEEPSMNEO-FFI
Neuroticism
NEO-FFI
Openness to experience
ETS1
102
LOT-ROptimism−0.0661
0.517
9999
LOT-RPessimism0.204*−0.247*1
0.0430.014
999999
PHQ-90.233*−0.567†0.312†1
0.0200.002
1009999100
RS-11−0.0730.546†−0.460†−0.572†1
0.474000
9999999999
BEE0.0320.259†−0.074−0.1760.407†1
0.7540.010.4680.0810
999999999999
PSM0.344†−0.0780.201*0.306†−0.0490.0111
00.4450.0460.0020.6310.912
10099991009999100
NEO-FFI0.104−0.578†0.467†0.631†−0.682†−0.284†0.238*1
Neuroticism0.31600000.0050.02
9595959595959595
NEO-FFI−0.0720.297†−0.167−0.090.302†0.1220.132−0.131
Openness to experience0.4920.0041090.3860.0030.2410.2050.211
949494949494949494
Cronbach’s alpha0.9010.7270.6080.90.90.7570.940.8540.726
  • *Correlation is significant at the 0.05 level (two tailed).

  • †Correlation is significant at the 0.01 level (two tailed).

  • BEE, Body Efficacy Expectation; ETS, Expectation for Treatment Scale; LOT-R, Life Orientation Test; NEO-FFI, NEO Five-Factor Inventory; PHQ-9, Patient Health Questionnaire-9; PSM, Perceived Sensitivity to Medicines Scale; RS-11, Die Resilienzskala-Ein Fragebogen zur Erfassung der psychischen Widerstandsfähigeit als Personenmerkmal.